In connection with the implementation of the project titled “Development and development of an innovative solution – a complex, three-component medicinal product, aimed at the treatment of hypertension”, funded from the state budget by the Medical Research Agency, Zakłady Farmaceutyczne Polpharma S.A., requested to submit a bid for purchase and delivery of active substance Ramipril.
Details of the price inquiry can be found in the documents attached below.
